CURITEVA RAISES $20.5 MILLION IN FUNDING ROUND (Orthopedics This Week)
Huntsville, Alabama-based Curiteva, Inc., a spinal device company, has closed its oversubscribed Series A private funding round at a total of $20.5 million.
The company initiated the funding round at the end of last year. Proceeds from the financing will go towards technology acquisitions, product development, and scaling manufacturing.
Curiteva’s Chief Executive Officer Mike English is an industry veteran with over 20 years of medical device experience at all leadership levels. English expressed appreciation stating, “We are sincerely grateful to our investors who expressed confidence in our strategic vision by investing personal capital during this uncertain time.”
Founded in 2017, Curiteva is a privately held medical technology and manufacturing company focused on spinal implant systems. Curiteva launched its first product in January 2019. Its product portfolio includes the APTITUDE standard and midline anterior cervical plate system, PRODIGY™ pedicle screw system, PRODIGY™ MIS pedicle screw system, SAGE cervical interbody fusion system, SAVANT posterior lumbar interbody fusion system, and SAVANT transfora...
